vimarsana.com

Latest Breaking News On - Atai life sciences chart - Page 1 : vimarsana.com

atai Life Sciences Announces Positive Initial Results from Beckley Psytech s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression Seite 1

27.03.2024 - - A single dose of BPL-003 demonstrated a rapid and durable antidepressant effect in TRD patients, with 45% of patients in clinical remission at week 12 - 55% of patients achieved a clinical response on the day after dosing and this rate of . Seite 1

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.